Newsworthy

Sept 18th Complimentary Hands-On Cognos TM1 Workshop – New York

Posted on

Complimentary Hands-On Cognos® TM1® Workshop at IBM’s offices:
Thursday, September 18th, 8:30AM
28 East 28th St, 8th F, New York, NY
              REGISTER HERE*

IBM Cognos® TM1® is an enterprise planning software platform that transforms your entire planning cycle, from target setting and budgeting to reporting, scorecarding, analysis, and forecasting.

What you will experience:

  • Powerful planning and analysis – Create and analyze sophisticated plans, budgets and forecasts, even those based on large data sets.
  • Integrated scorecards and strategy management – Model metrics to measure progress toward objectives and link them dynamically to actions and forecasts.
  • Flexible modeling – Develop and deploy even the most complex planning and analysis models using a guided modeling environment.
  • Engagement with more users – Engage users from across the organization in high-participation planning;  Collaborate with remote and distributed users through a range of mobile devices, including the Apple iPad — no more passing around an endless stream of spreadsheets!
  • Cloud-based deployment option with enhanced collaboration & mobile capabilities. See how a hosted solution can get you started quicker and improve the way you work with others.

To register for this instructor-led session, click HERE*  The session is free, but space is limited.

The session runs from 8:30am until 4pm. Lunch is provided.

Available as an on-premise or on-cloud solution, and with extensive mobile capabilities, Cognos TM1 enables you to collaborate on plans, budgets and forecasts.  You can analyze data, and create models – including profitability models – to reflect a constantly evolving business environment.  In addition, integrated scorecards and strategy management capabilities help you monitor performance metrics and align resources and initiatives with corporate objectives and market events.

By urgent hyperlink partnering with harvard’s world-class biomedical research division, I am delighted to help accelerate the development of new therapies, says blavatnik
This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.


Our Partners